AMP-activated Protein Kinase α2 and E2F1 Transcription Factor Mediate Doxorubicin-induced Cytotoxicity by Forming a Positive Signal Loop in Mouse Embryonic Fibroblasts and Non-carcinoma Cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AMP-activated Protein Kinase α2 and E2F1 Transcription Factor Mediate Doxorubicin-induced Cytotoxicity by Forming a Positive Signal Loop in Mouse Embryonic Fibroblasts and Non-carcinoma Cells
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 289, Issue 8, Pages 4839-4852
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2014-01-08
DOI
10.1074/jbc.m113.496315
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Dark Side of E2F1: In Transit beyond Apoptosis
- (2012) D. Engelmann et al. CANCER RESEARCH
- Resveratrol Attenuates Doxorubicin-Induced Cardiomyocyte Apoptosis in Lymphoma Nude Mice by Heme Oxygenase-1 Induction
- (2012) Jun Gu et al. Cardiovascular Toxicology
- Bim, a Proapoptotic Protein, Up-regulated via Transcription Factor E2F1-dependent Mechanism, Functions as a Prosurvival Molecule in Cancer
- (2012) Raghu Gogada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of AMP-activated Protein Kinase α (AMPKα) by Doxorubicin Accentuates Genotoxic Stress and Cell Death in Mouse Embryonic Fibroblasts and Cardiomyocytes
- (2012) Shaobin Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Berberine Inhibits Doxorubicin-Triggered Cardiomyocyte Apoptosis via Attenuating Mitochondrial Dysfunction and Increasing Bcl-2 Expression
- (2012) Xiuxiu Lv et al. PLoS One
- Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53
- (2011) C. Zhang et al. CARDIOVASCULAR RESEARCH
- Activation of AMP-Activated Protein Kinase Contributes to Doxorubicin-Induced Cell Death and Apoptosis in Cultured Myocardial H9c2 Cells
- (2011) Min-Bin Chen et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- AMP-activated protein kinase--an energy sensor that regulates all aspects of cell function
- (2011) D. G. Hardie GENES & DEVELOPMENT
- Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation
- (2010) Masanori Konishi et al. CARDIOVASCULAR RESEARCH
- Inhibition of AMP-activated protein kinase pathway sensitizes human leukemia K562 cells to nontoxic concentration of doxorubicin
- (2010) Qun Zhu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition
- (2010) C Ji et al. ONCOGENE
- Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation
- (2010) Amy V. Pointon et al. PLoS One
- Doxorubicin: The Good, the Bad and the Ugly Effect
- (2009) Cristina Carvalho et al. CURRENT MEDICINAL CHEMISTRY
- Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway
- (2009) Elizabeth D. Brookins Danz et al. FREE RADICAL BIOLOGY AND MEDICINE
- AMPK: Lessons from transgenic and knockout animals
- (2009) Benoit Viollet Frontiers in Bioscience-Landmark
- E2F1 transcription is induced by genotoxic stress through ATM/ATR activation
- (2009) Abel L. Carcagno et al. IUBMB LIFE
- An E2F1-Dependent Gene Expression Program that Determines the Balance between Proliferation and Cell Death
- (2008) Timothy C. Hallstrom et al. CANCER CELL
- E2F-like elements in p27Kip1promoter specifically sense deregulated E2F activity
- (2008) Eiko Ozono et al. GENES TO CELLS
- LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis
- (2008) Pekka Katajisto et al. NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More